CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Thomas Hughes, Ph.D., president and chief executive officer has been selected to participate on a panel at the BIO 2009 International Convention on Tuesday, May 19, 2009 at 5:00 p.m. (EDT) at the Georgia World Congress Center in Building A, Level 4.
